期刊文献+

克罗恩病的治疗 被引量:8

The treatment of Crohn's disease.
原文传递
导出
摘要 克罗恩病(CD)是一种以肠道为主的自身免疫性病变,临床表现复杂多样,其治疗涉及药物治疗(包括传统药物、新型生物制剂)、外科治疗、营养治疗和心理治疗等方面。应依据病情的活动度、严重程度、病程、病变范围以及并发症等因素制定综合的个体化治疗方案。 Crohn's Disease(CD) is an autoimmune inflammatory condition of unknown etiology that can af- fect any portion of the gastrointestinal tract. Management of CD includes traditional medical treatment, novel biologic agent treatment, surgical treatment, nutrition and psychological intervention. Given the heterogeneity of the disease,combining and individualized treatment should be carried according to the disease activity, severity, course, anatomic extension and different complications.
作者 李玥 朱峰
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第3期239-240,共2页 Chinese Journal of Practical Internal Medicine
关键词 克罗恩病 生物制剂 Crohn's disease biologic agent
  • 相关文献

同被引文献54

  • 1Joon Mee Kim,Hyung Kil Kim,Lucia Kim,Suk Jin Choi,In Suh Park,Jee Young Han,Young Chae Chu,Kye Sook Kwon,Eun Joo Kim.Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn’s disease[J].World Journal of Gastroenterology,2010,16(20):2496-2503. 被引量:20
  • 2YANG S K, YUN S, KIM J H, et al. Epidemiology of inflammatory bowel in the Songpakangdong district, Seoul, Korea, 1986 - 2005: a KASID study[J]. In- flamm Bowel Dis, 2008,14 : 542 - 549.
  • 3THIA K T, LOFTUS E V Jr,SANDBORN W J,et al. An update on the epidemiology of inflammatory bowel disease in Asia[J]. Am J Gastroenterol, 2008, 103: 3167-3182.
  • 4WANG Y F, OUYANG Q, HU R W. Progression of inflammatory bowel disease in China[J]. J Dig Dis, 2010,11 : 76-82.
  • 5SEOW C H, BENCHIMOI. E I, GRIFFITHS A M, et al. Budesonide for induction of remission in Crohn's disease[J]. Coehrane Database Syst Rev, 2008 (3): CD000296.
  • 6LICHTENSTEIN G R, YAN S, BAIZA M, et al. In- fliximab maintenance treatment reduces hospitaliza- tions, surgeries, and procedures in fistulizing Crohn'sdisease[J]. Gastroenterology, 2005,128 : 862- 869.
  • 7ATKINS D, BEST D, BRISS P A, et, al. Grading quali ty of evidence and strength of recommendations [J]. BMJ, 2004,328 : 1490- 1490.
  • 8PRESENT D H, RUTGEERTS P, TARGAN S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease[J]. N Engl J Med, 1999,340: 1398- 1405.
  • 9REGUEIRO M, SCHRAUT W, BAIIXX) L, et al. In- fliximab prevents Crohn's disease recurrence after ileal resection[J]. Gastroenterology, 2009,136 : 441-450.
  • 10HANAUER SB, FEAGAN B G, LICHTENSTEIN G R,et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial[J]. Lancet, 2002,359: 1541-1549.

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部